Sunday, August 29- Virtual Conference

LIVE SESSIONS

Please note that all times below refer to the Indian Standard Time zone.

OPENING SESSION |  08:30- 08:55 hours

Rare disease policy and implications in IEM

Dr. Madhulika Kabra

India

Chair: Dr. Radha Rama Devi

India

CONCURRENT SESSION 3 | 09:00 - 11:05 hours

CO3: Building strategies for IEM patient cohorts and follow up

Chairs: Dr. Kaushik Mandal

India

CO3.1: Challeges in the treatment of patient with Gaucher disease (9:00-9:25)

Dr. Mamta Muranjan

India

CO3.2:  Ultra-rare cardiac variant in Gaucher disease: type IIIC, our experience (9:25- 9:50)

Dr. Meenakshi Bhat

India

Co3.3:  Follow up of patients with Treatable Inborn Error of Metabolism (9:50- 10:15)

Dr. Inusha Panigrahi

India

CO3.4:  Alkaptonuria: Our experience at CMC Vellore ( 10:15- 10:40)

Dr. Sumita Danda

India

CO3.5:  MPS type IV: management and follow-up (10:40- 11:05)

Dr. Sujatha Jagdeesh

India

CONCURRENT SESSION 4 | 09:00 - 11:05 hours

CO4: Enzymatic, nutritional and dietic treatment approaches 

Chairs: Dr. Parag Dagli

India

CO4.1: B complex vitamins in IEM treatment (9:00- 9:25)

Dr. Koumudi Godbole

India

CO4.2:  Nutrition in carbohydrate metabolic disorders (9:25 -9:50)

Dr. Suvarna Magar

India

CO4.3:  Vitamin Responsive Epilepsy and Epilepsy Encephalopathy in IEM disorders (9:50- 10:15)

Dr. Harsh Patel

India

CO4.4:  Effect of genotype on phenotype and challenges in treating MPS children (10:15- 10:40)

Dr. Prajnya Ranganathan

India

CO4.5: Management of (Intermediary) IEMs in the Molecular era (10:40- 11:05)

Dr. Chaitanya Datar

India

TEA BREAK| 10 mins

WORKSHOP 2 |  11:15- 12: 20 hours

Interpreting next generation sequencing data

Dr. Sridhar Sivasubbu

India

Chair: Dr. Harsh Sheth

India

LUNCH BREAK | 12:20 - 12:50 hours

VIRTUAL POSTER PRESENTATION | 12:50 - 14:20 hours
Judges: Dr. Ashwin Dalal and Dr. Alpa Dherai | Moderator: Dr. Harsh Sheth

SWITCHING ROOMS FOR PLENARY SESSION - 10 mins

PLENARY SESSION 3 | 14:30 - 16:00 hours

PL3: Mechanistic understanding of IEMs

Chairs: Dr. Uma Ramaswamy

India

PL3.1: Adult onset IEMs (14:30- 15:00)

Prof. Sir John Burn

UK

PL3.2: Lysosomal Function and Dysfunction with relevance to LSDs (15:00- 15:30)

Dr. Ashok Vellodi

UK

PL3.3: An overview of Liver Gene therapy and UCDs (15:30- 16:00)

Prof. Julien Baruteau

UK

TEA BREAK-  15 mins

CONCURRENT SESSION 5 | 16:10 - 17:50 hours

CO5: IEM Disorders: Biochemical diagnostic strategies

Chairs: Dr. Harsuti  Shah

India

CO5.1: Clinical diagnosis and management of cystic fibrosis (16:10- 16:35)

Dr. Khanjan Shah

India

CO5.2: How and when to suspect an IEM and its management (16:35- 17:00)

Dr. Sunita Bijarnia

India

CO5.3: Small molecule IEM disorders (17:00- 17:25)

Dr. Neerja Gupta

India

CO5.4: TMS vs GC/MS in IEM Screening & Diagnosis- Benefits & Limitations (17:25 -17:50)

Dr. Usha Dave

India

CONCURRENT SESSION 6 | 16:10 - 17:50 hours

CO6: Going forward in detecting and treating IEMs

Chairs: Dr. Udaya Kotecha

India 

CO6.1: When to suspect, diagnosis and Management of mitochondrial disorders (16:10- 16:35)

Prof V Raju

India

CO6.2: CAH an under diagnosed IEM: Our experience (16:35- 17:00)

Dr. Shalmi Mehta

India

CO6.3: When to suspect GSDs and its management (17:00- 17:25)

Dr. Madhulika Kabra

India

CO6.4: Repurposing Natural Products following the principles of Pharmacology with focus on  Gaucher disease and ALD (17:25- 17:50)

Dr. Reena Kartha

USA

SWITCHING ROOMS FOR CONCLUDING SESSION- 5 mins

CONFERENCE CONCLUSION | 18:00 - 18:15 hours 

Prize distribution and important announcements (18:00- 18:07)

Dr. Jayesh Sheth and Dr. Radha Rama Devi

Vote of thanks (18:07- 18:15)

Dr. Harsh Sheth